Bilgi Ana Sayfa İnsan Sağlığı Bilgi All Görüş Belgeler Popüler Bilim Mülakatlar Süzgeç Therapeutic areas COVID-19 Sindirim sağlığı Apply Ana Sayfa İnsan Sağlığı Bilgi Mechanism of action of an adjuvanted protein vaccine based on the RBD from SARS-CoV-2 Spike protein Ana Sayfa İnsan Sağlığı Bilgi Safety and Immunogenicity of PHH-1V Booster Against SARS-CoV-2 Variants, Including Omicron Subvariants: Results from a Phase IIb Open-Label Extension Study Ana Sayfa İnsan Sağlığı Bilgi Rethinking optimal immunogens to face SARS-CoV-2. Evolution through vaccination Ana Sayfa İnsan Sağlığı Bilgi Antibody and B-cell responses to PHH-1V81 XBB.1.16-adapted SARS-CoV-2 booster vaccination are associated with variant neutralization Ana Sayfa İnsan Sağlığı Bilgi Immunogenicity and safety of PHH-1V COVID-19 vaccine as a heterologus booster in adolescents Ana Sayfa İnsan Sağlığı Bilgi 34th ECCMID Integrated Symposium, 2024: COVID-19 booster immunization Ana Sayfa İnsan Sağlığı Bilgi Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial Ana Sayfa İnsan Sağlığı Bilgi Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 Ana Sayfa İnsan Sağlığı Bilgi Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates Daha fazlasını yükle
